Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Biotech Startup Rubius to Double Footprint With New Kendall Square Lease

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

The fast-growing company will anchor 399 Binney St., an Alexandria Real Estate Equities property. Source: BioSpace

Continue ReadingBiotech Startup Rubius to Double Footprint With New Kendall Square Lease

3 Biotech Gems to Stock Up on This Month

  • Post author:Sam
  • Post published:February 11, 2018
  • Post category:BioPharma

A look at a few bargains in today's choppy market. Source: BioSpace

Continue Reading3 Biotech Gems to Stock Up on This Month

FDA Officials Discuss Sentinel’s Challenges

  • Post author:Sam
  • Post published:February 9, 2018
  • Post category:Drug Industry Daily

The biggest challenge for the FDA’s 10-year-old Sentinel program for post-market safety monitoring of medical products is having to deal with a wide range of partners and data sources, according…

Continue ReadingFDA Officials Discuss Sentinel’s Challenges

CEA Report: How Government Can Reduce Drug Prices, Increase Innovation in Pharma

  • Post author:Sam
  • Post published:February 9, 2018
  • Post category:Drug Industry Daily

The Council of Economic Advisers issued new recommendations for reducing drug pricing, including changes in government policies and regulations, such as moving Medicare Part B drug coverage into Part D.…

Continue ReadingCEA Report: How Government Can Reduce Drug Prices, Increase Innovation in Pharma

Budget Deal Boosts Discretionary Spending, But Unclear How Much FDA Will Benefit

  • Post author:Sam
  • Post published:February 9, 2018
  • Post category:Drug Industry Daily

The budget deal approved by lawmakers in the early hours on Friday raised caps on non-defense discretionary spending by $63 billion in fiscal 2018 and $68 billion in fiscal 2019,…

Continue ReadingBudget Deal Boosts Discretionary Spending, But Unclear How Much FDA Will Benefit

Wuhan Warned for Quality Controls, Adulterated Products

  • Post author:Sam
  • Post published:February 9, 2018
  • Post category:Drug Industry Daily

The FDA issued Wuhan Chinese Moxibustion Technology a warning letter for manufacturing adulterated products, and for quality and sanitation deficiencies. Source: Drug Industry Daily

Continue ReadingWuhan Warned for Quality Controls, Adulterated Products

Bipartisan Senate Bill Would Give NIH More Leeway to Explore Opioid Alternatives

  • Post author:Sam
  • Post published:February 9, 2018
  • Post category:Drug Industry Daily

A bipartisan group of members of the Senate Health Committee introduced a bill to increase National Institutes of Health research into non-opioid pain treatments. Source: Drug Industry Daily

Continue ReadingBipartisan Senate Bill Would Give NIH More Leeway to Explore Opioid Alternatives

Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Elastagen's revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin. Source: BioSpace

Continue ReadingAllergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

Clinical-Stage Biotech Stock Might Outperform Amgen

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

This biotech could potentially could be a better value. Source: BioSpace

Continue ReadingClinical-Stage Biotech Stock Might Outperform Amgen

Boehringer Ingelheim Ditches Phase II Alzheimer's Program

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:BioPharma

Another potential treatment for Alzheimer's disease has been tossed into the rubbish bin. Source: BioSpace

Continue ReadingBoehringer Ingelheim Ditches Phase II Alzheimer's Program
  • Go to the previous page
  • 1
  • …
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.